has approved the freeze-dried formulation of JYNNEOS ® (Smallpox and Mpox Vaccine, Live, Non-replicating) for prevention of smallpox and mpox disease in adults 18 years of age and older.
The company said the newly approved formulation of its vaccine ... and safety between the freeze-dried and liquid-frozen formulations, the company said. Freeze-drying is a method used to remove ...
COPENHAGEN, Denmark, March 31, 2025 – Bavarian Nordic A/S (OMX: BAVA) today announced that the U.S. Food and Drug Administration (FDA) has approved the freeze-dried formulation of JYNNEOS ® (Smallpox ...
(Reuters) -Denmark's Bavarian Nordic said on Monday the U.S. Food and Drug Administration has approved a freeze-dried formulation of its mpox and smallpox vaccine. The company ... the company said.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results